InterVenn Biosciences Collaborates with Aranscia to Enhance Ovarian Cancer Diagnostic Solutions InterVenn Biosciences and Aranscia have teamed up to streamline the commercial rollout of the GlycoKnow™ test for ovarian cancer, enhancing diagnostic capabilities.

InterVenn Biosciences Collaborates with Aranscia to Enhance Ovarian Cancer Diagnostic Solutions #United_States #South_San_Francisco #Aranscia #InterVenn_Biosciences #GlycoKnow

Aranscia Acquires Spesana #healthIT #Aranscia #Spesana
www.healthcareittoday.com/?p=2523767

Neurogen Biomarking Teams up with Aranscia for Early Alzheimer's Detection Neurogen Biomarking collaborates with Aranscia to enhance early detection of Alzheimer's disease through advanced diagnostic technology and patient support.

Neurogen Biomarking Teams up with Aranscia for Early Alzheimer's Detection #USA #Chicago #Alzheimer's #Aranscia #Neurogen

Aranscia Expands Its Portfolio with the Acquisition of Spesana Aranscia has strengthened its position in healthcare technology by acquiring Spesana, known for its advanced clinical decision tools, increasing efficiency in patient navigation.

Aranscia Expands Its Portfolio with the Acquisition of Spesana #USA #Houston #healthcare_technology #Aranscia #Spesana